Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
Background: The association between anticoagulation outcomes and prior history of venous thromboembolism (VTE) in chronic thromboembolic pulmonary hypertension (CTEPH) has not been established. This study aimed to compare the efficacy and safety of anticoagulation treatment in CTEPH patients with an...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-05-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.628284/full |
| _version_ | 1819090517927919616 |
|---|---|
| author | Yong-Jian Zhu Yu-Ping Zhou Yun-Peng Wei Xi-Qi Xu Xin-Xin Yan Chao Liu Xi-Jie Zhu Zi-Yi Liu Kai Sun Lu Hua Xin Jiang Zhi-Cheng Jing |
| author_facet | Yong-Jian Zhu Yu-Ping Zhou Yun-Peng Wei Xi-Qi Xu Xin-Xin Yan Chao Liu Xi-Jie Zhu Zi-Yi Liu Kai Sun Lu Hua Xin Jiang Zhi-Cheng Jing |
| author_sort | Yong-Jian Zhu |
| collection | DOAJ |
| description | Background: The association between anticoagulation outcomes and prior history of venous thromboembolism (VTE) in chronic thromboembolic pulmonary hypertension (CTEPH) has not been established. This study aimed to compare the efficacy and safety of anticoagulation treatment in CTEPH patients with and without prior history of VTE.Methods: A total of 333 CTEPH patients prescribed anticoagulants were retrospectively included from May 2013 to April 2019. The clinical characteristics were collected at their first admission. Incidental recurrent VTE and clinically relevant bleeding were recorded during follow-up. The Cox proportional regression models were used to identify potential factors associated with recurrent VTE and clinically relevant bleeding.Results: Seventy patients (21%) without a prior history of VTE did not experience recurrent VTE during anticoagulation. Compared to CTEPH patients without a prior history of VTE, those with a prior history of VTE had an increased risk of recurrent VTE [2.27/100 person-year vs. 0/100 person-year; hazard ratio (HR), 8.92; 95% confidence interval (CI), 1.18–1142.00; P = 0.029] but a similar risk of clinically relevant bleeding (3.90/100 person-year vs. 4.59/100 person-year; HR, 0.83; 95% CI, 0.38–1.78; P = 0.623). Multivariate Cox analyses suggested that a prior history of VTE and interruption of anticoagulation treatments were significantly associated with an increased risk of recurrent VTE, while anemia and glucocorticoid use were significantly associated with a higher risk of clinically relevant bleeding.Conclusions: This study is the first to reveal that a prior history of VTE significantly increases the risk of recurrent VTE in CTEPH patients during anticoagulation treatment. This finding should be further evaluated in prospective studies. |
| first_indexed | 2024-12-21T22:25:06Z |
| format | Article |
| id | doaj.art-7e3d0708c83a40a58a39f37c0904f115 |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-12-21T22:25:06Z |
| publishDate | 2021-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-7e3d0708c83a40a58a39f37c0904f1152022-12-21T18:48:14ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-05-01810.3389/fcvm.2021.628284628284Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary HypertensionYong-Jian Zhu0Yu-Ping Zhou1Yun-Peng Wei2Xi-Qi Xu3Xin-Xin Yan4Chao Liu5Xi-Jie Zhu6Zi-Yi Liu7Kai Sun8Lu Hua9Xin Jiang10Zhi-Cheng Jing11Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pulmonary Vascular Disease and Thrombosis Medicine, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, FuWai Hospital, Chinese Academy Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pulmonary Vascular Disease and Thrombosis Medicine, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, FuWai Hospital, Chinese Academy Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaBackground: The association between anticoagulation outcomes and prior history of venous thromboembolism (VTE) in chronic thromboembolic pulmonary hypertension (CTEPH) has not been established. This study aimed to compare the efficacy and safety of anticoagulation treatment in CTEPH patients with and without prior history of VTE.Methods: A total of 333 CTEPH patients prescribed anticoagulants were retrospectively included from May 2013 to April 2019. The clinical characteristics were collected at their first admission. Incidental recurrent VTE and clinically relevant bleeding were recorded during follow-up. The Cox proportional regression models were used to identify potential factors associated with recurrent VTE and clinically relevant bleeding.Results: Seventy patients (21%) without a prior history of VTE did not experience recurrent VTE during anticoagulation. Compared to CTEPH patients without a prior history of VTE, those with a prior history of VTE had an increased risk of recurrent VTE [2.27/100 person-year vs. 0/100 person-year; hazard ratio (HR), 8.92; 95% confidence interval (CI), 1.18–1142.00; P = 0.029] but a similar risk of clinically relevant bleeding (3.90/100 person-year vs. 4.59/100 person-year; HR, 0.83; 95% CI, 0.38–1.78; P = 0.623). Multivariate Cox analyses suggested that a prior history of VTE and interruption of anticoagulation treatments were significantly associated with an increased risk of recurrent VTE, while anemia and glucocorticoid use were significantly associated with a higher risk of clinically relevant bleeding.Conclusions: This study is the first to reveal that a prior history of VTE significantly increases the risk of recurrent VTE in CTEPH patients during anticoagulation treatment. This finding should be further evaluated in prospective studies.https://www.frontiersin.org/articles/10.3389/fcvm.2021.628284/fullanticoagulationchronic thromboembolic pulmonary hypertensionvenous thromboembolismbleedingrecurrence |
| spellingShingle | Yong-Jian Zhu Yu-Ping Zhou Yun-Peng Wei Xi-Qi Xu Xin-Xin Yan Chao Liu Xi-Jie Zhu Zi-Yi Liu Kai Sun Lu Hua Xin Jiang Zhi-Cheng Jing Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension Frontiers in Cardiovascular Medicine anticoagulation chronic thromboembolic pulmonary hypertension venous thromboembolism bleeding recurrence |
| title | Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension |
| title_full | Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension |
| title_fullStr | Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension |
| title_full_unstemmed | Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension |
| title_short | Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension |
| title_sort | association between anticoagulation outcomes and venous thromboembolism history in chronic thromboembolic pulmonary hypertension |
| topic | anticoagulation chronic thromboembolic pulmonary hypertension venous thromboembolism bleeding recurrence |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2021.628284/full |
| work_keys_str_mv | AT yongjianzhu associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT yupingzhou associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT yunpengwei associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT xiqixu associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT xinxinyan associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT chaoliu associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT xijiezhu associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT ziyiliu associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT kaisun associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT luhua associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT xinjiang associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension AT zhichengjing associationbetweenanticoagulationoutcomesandvenousthromboembolismhistoryinchronicthromboembolicpulmonaryhypertension |